In MS, lower BDNF concentrations—mostly in serum, but also in CSF—were found compared to healthy controls in most studies [12–16] though some studies showed no difference [12, 17–19] or even higher BDNF levels in MS patients [12, 14, 16, 20–23]. This evidence concerns the gene BDNF and myeloid sarcoma.